← Back
Data updated: Mar 10, 2026
PADDOCK LLC
ImmunologyDermatology
PADDOCK LLC is a generic drug manufacturer focused on Immunology, Dermatology.
1983
Since
10
Drugs
-
Trials
87
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
NYSTATIN 2026-02-05
DICLOFENAC SODIUM 2025-12-31
Labeling
DICLOFENAC SODIUM 2025-11-05
DICLOFENAC SODIUM 2025-09-26
Labeling
ERYTHROMYCIN 2025-09-23
POLYMYXIN B SULFATE 2025-07-03
Labeling
POLYMYXIN B SULFATE 2025-07-03
Labeling
POLYMYXIN B SULFATE 2025-07-03
Labeling
POLYMYXIN B SULFATE 2025-07-03
Labeling
POLYMYXIN B SULFATE 2025-07-03
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 50%
1 drugs
Dermatology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (6)
Company Info
- First Approval
- 1983-04-08
- Latest
- 2010-06-07
- Applications
- 12
FDA Sponsor Names
PADDOCK LLCPADDOCK LABS